Alumis

Developer of therapeutics for the treatment of auto-immune disease

placeSan Francisco, California, United States calendar_todayFounded 2003 groups16 employees language alumis.com

Registered entities

Social engagement

Social engagement: 9.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Foresite Capital, Samsara BioCapital, VenBio, General Atlantic.

Investor typeCountShare
Venture capital956%
Private equity319%
Bank & private debt16%
Other / undisclosed319%

Hiring activity

Hires periodically

9 roles tracked across 5 of the last 12 months

7 May 2026 · Vice President Corporate Communications & Investor Relations · South San Francisco

10 Mar 2026 · Data Systems & Clinical Programming Specialist (Contractor) · South San Francisco

9 Mar 2026 · Senior Clinical Development (Medical Director), Dermatology · South San Francisco

14 Jan 2026 · Director, Statistical Programming · South San Francisco

24 Oct 2025 · Senior Director, Business Insights and Analytics · South San Francisco

Based on job postings tracked across public sources.

Coming soon